Agency Forms Undergoing Paperwork Reduction Act Review, 26962-26963 [2010-11413]
Download as PDF
<![CDATA[
26962
Federal Register / Vol. 75, No. 92 / Thursday, May 13, 2010 / Notices
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than June 7, 2010.
A. Federal Reserve Bank of San
Francisco (Kenneth Binning, Vice
President, Applications and
Enforcement) 101 Market Street, San
Francisco, California 94105–1579:
1. Carpenter Fund Manager GP, LLC,
Carpenter Fund Management, LLC,
Carpenter Community Bancfund, L.P.,
Carpenter Community Bancfund-A, LP,
Carpenter Community Bancfund-CA,
L.P., SCJ, Inc., and CCFW, Inc., all of
Irvine, California; to acquire no more
than 35 percent of the voting shares of
Bridge Capital Holdings, and thereby
indirectly acquire voting shares of
Bridge Bank, N.A., both of San Jose,
California.
SUMMARY: The Federal Trade
Commission published a document in
the Federal Register of April 15, 2010,
seeking public comments on its
proposal to extend through May 31,
2013, the current Paperwork Reduction
Act clearance for information collection
requirements associated with the
Contact Lens Rule (the Rule), 16 CFR
part 315. The document contained an
incorrect OMB Control No. for the preexisting clearance. The correct number
is 3084-0127.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the proposed information
requirements should be addressed to
Karen Jagielski, Attorney, Division of
Advertising Practices, Bureau of
Consumer Protection, Federal Trade
Commission, 600 Pennsylvania Avenue,
NW., NJ– 3212, Washington, DC 20580,
(202) 326–2509. Correction In the
Federal Register of April 15, 2010, in
FR Doc. 2010–8647, on page 19647, in
the third column, under Supplementary
Information: Background, correct the
second paragraph, third sentence, to
read: ‘‘Pursuant to the OMB regulations,
5 CFR Part 1320, that implement the
PRA, the FTC is providing this second
opportunity for public comment while
seeking OMB approval to renew the preexisting clearance for the Rule (OMB
Control No. 3084-0127).’’
By direction of the Commission.
Board of Governors of the Federal Reserve
System, May 10, 2010.
Robert deV. Frierson,
Deputy Secretary of the Board.
Agency Forms Undergoing Paperwork
Reduction Act Review
[FR Doc. 2010–11440 Filed 5–12–10; 8:45 am]
BILLING CODE 6210–01–S
sroberts on DSKD5P82C1PROD with NOTICES
FEDERAL TRADE COMMISSION
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Correction
AGENCY: Federal Trade Commission
(‘‘FTC’’ or ‘‘Commission’’).
ACTION: Notice; correction.
VerDate Mar<15>2010
18:12 May 12, 2010
Jkt 220001
Donald S. Clark
Secretary.
[FR Doc. 2010–11501 Filed 5–12–10; 8:45 am]
BILLING CODE: 6750–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–10–0539]
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an
e-mail to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Proposed Project
Estimating the Capacity for National
and State-Level Colorectal Cancer
Screening through a Survey of
Endoscopic Capacity (SECAP II)(OMB
No. 0920–0539, exp.
3/31/2003)—Reinstatement with
Change—Division of Cancer Prevention
and Control, National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Colorectal cancer (CRC) is the second
leading cause of cancer-related deaths in
the United States (U.S.). Most colorectal
cancers develop from pre-existing
growths, or polyps, which slowly
transform into cancers over a period of
10–20 years. As a result, CRC is ideally
suited for prevention and early
detection through regular screening.
Recommended screening procedures
include flexible sigmoidoscopy and
colonoscopy, which allow qualified
medical professionals to identify and
remove polyps as well as to detect early
cancers. Information regarding the
capacity of the U.S. health care system
to provide lower GI endoscopic
procedures is critical to planning
widespread CRC screening programs.
CDC requests OMB approval to
reinstate a previously approved data
collection, formerly entitled the
National Survey of Endoscopic Capacity
(SECAP) (OMB No. 0920–0539, exp. 3/
31/2003), to obtain a current estimate of
the number of colorectal cancer
screening and follow-up tests being
performed, as well as the maximum
number of screening and follow-up tests
that could be performed in the event of
widespread screening. In addition, the
reinstatement request describes a plan
to conduct state-specific surveys in up
to 18 selected states. Similar surveys
were conducted in 15 selected states
from 2003 to 2005, and provided
estimates of endoscopic screening
capacity at state and sub-state levels
(State Survey of Endoscopic Capacity,
OMB No. 0920–0590, exp. 6/30/2006).
However, in light of recent trends in
colorectal cancer screening (e.g.,
increases in the percentage of public
and private insurers that reimburse for
screening colonoscopy, increased use of
colonoscopy and decreased use of
flexible sigmoidoscopy, availability of
other colorectal cancer screening
procedures), there is a need to update
estimates of endoscopic capacity to
guide continued screening initiatives.
OMB approval is requested for three
years. The proposed national survey
will be conducted in 2010–2011 and
E:\FR\FM\13MYN1.SGM
13MYN1
26963
Federal Register / Vol. 75, No. 92 / Thursday, May 13, 2010 / Notices
will be based on an updated version of
the previously fielded paper-and-pencil
survey instrument. The target
population for the national survey is all
facilities in the U.S. that use lower
gastrointestinal flexible endoscopic
equipment for the detection of
colorectal cancer in adults. Information
will be collected from a random sample
of 1,440 facilities, stratified by U.S.
Census region and urban/rural location.
Additional state-level surveys will be
conducted from approximately 2010–
2012 and will include a census survey
of up to 18 selected states, based on
methodology employed with the
previously fielded state-based survey.
An average of 135 facilities will be
selected to participate in each state. A
total of approximately 1,680 completed
state surveys will be collected over the
three years of the project.
Facilities will be recruited and
screened through a telephone interview.
Participation is voluntary. The
information collection will inform
planning efforts for national and state
colorectal cancer screening.
There are no costs to respondents
other than their time. The total
estimated burden hours are 732.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Medical Facilities
Screening.
that
Perform
CRC
Number of
responses per
respondent
Number of
respondents
Form name
Average
burden per
response
(in hours)
National Survey Recruitment Interview .......
700
1
5/60
National SECAP Survey ..............................
State Survey Recruitment Interview ............
State SECAP Survey ..................................
480
800
560
1
1
1
35/60
5/60
35/60
Carol Walker,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2010–11413 Filed 5–12–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–D–0043]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Guidance for
Industry on How to Use E-Mail to
Submit a Request for a Meeting or
Teleconference in Electronic Format to
the Center for Veterinary Medicine
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
sroberts on DSKD5P82C1PROD with NOTICES
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by June 14,
2010.
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or e-mailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0452. Also
include the FDA docket number found
in brackets in the heading of this
document.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., P150–
400B, Rockville, MD 20850, 301–796–
3793.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Guidance for Industry on How to Use
E-Mail to Submit a Request for a
Meeting or Teleconference in Electronic
Format to the Center for Veterinary
Medicine—(OMB Control Number
0910–0452)—Extension
CVM holds meetings and/or
teleconferences when a sponsor requests
a presubmission conference under 21
CFR 514.5, or requests a meeting to
discuss general questions. Generally,
meeting requests are submitted to CVM
on paper. However, CVM now allows
registered sponsors to submit
information electronically, and to
request meetings electronically, if they
determine this is more efficient and
time saving for them. CVM’s guidance
on ‘‘How to Submit a Request for a
Meeting or Teleconference in Electronic
Format to CVM,’’ provides sponsors
with the option to submit a request for
a meeting or teleconference as an e-mail
attachment by the Internet. The likely
respondents are sponsors for new
animal drug applications.
In the Federal Register of February 5,
2010 (75 FR 6035), FDA published a 60day notice requesting public comment
on the proposed collection of
information.
In response, two comments were
received. One comment was completely
outside the scope of the notice and the
other requested that FDA meet openly
with industry rather than closed
sessions. Neither comment addressed
the paperwork involved in the
information collection.
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
21 CFR Section/
FDA Form 3489
No. of
Respondents
10.64
1 There are
2 Electronic
VerDate Mar<15>2010
Annual Frequency
per Response
40
2.4
Total Annual
Responses2
Hours per
Response
96
.08
no capital costs or operating and maintenance costs associated with this collection of information.
submissions received between January 1, 2008, and December 31, 2008.
15:56 May 12, 2010
Jkt 220001
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
E:\FR\FM\13MYN1.SGM
Total Hours
13MYN1
7.7
]]>Agencies
[Federal Register Volume 75, Number 92 (Thursday, May 13, 2010)]
[Notices]
[Pages 26962-26963]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-11413]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-10-0539]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-5806.
Written comments should be received within 30 days of this notice.
Proposed Project
Estimating the Capacity for National and State-Level Colorectal
Cancer Screening through a Survey of Endoscopic Capacity (SECAP II)(OMB
No. 0920-0539, exp. 3/31/2003)--Reinstatement with Change--Division of
Cancer Prevention and Control, National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Colorectal cancer (CRC) is the second leading cause of cancer-
related deaths in the United States (U.S.). Most colorectal cancers
develop from pre-existing growths, or polyps, which slowly transform
into cancers over a period of 10-20 years. As a result, CRC is ideally
suited for prevention and early detection through regular screening.
Recommended screening procedures include flexible sigmoidoscopy and
colonoscopy, which allow qualified medical professionals to identify
and remove polyps as well as to detect early cancers. Information
regarding the capacity of the U.S. health care system to provide lower
GI endoscopic procedures is critical to planning widespread CRC
screening programs.
CDC requests OMB approval to reinstate a previously approved data
collection, formerly entitled the National Survey of Endoscopic
Capacity (SECAP) (OMB No. 0920-0539, exp. 3/31/2003), to obtain a
current estimate of the number of colorectal cancer screening and
follow-up tests being performed, as well as the maximum number of
screening and follow-up tests that could be performed in the event of
widespread screening. In addition, the reinstatement request describes
a plan to conduct state-specific surveys in up to 18 selected states.
Similar surveys were conducted in 15 selected states from 2003 to 2005,
and provided estimates of endoscopic screening capacity at state and
sub-state levels (State Survey of Endoscopic Capacity, OMB No. 0920-
0590, exp. 6/30/2006). However, in light of recent trends in colorectal
cancer screening (e.g., increases in the percentage of public and
private insurers that reimburse for screening colonoscopy, increased
use of colonoscopy and decreased use of flexible sigmoidoscopy,
availability of other colorectal cancer screening procedures), there is
a need to update estimates of endoscopic capacity to guide continued
screening initiatives.
OMB approval is requested for three years. The proposed national
survey will be conducted in 2010-2011 and
[[Page 26963]]
will be based on an updated version of the previously fielded paper-
and-pencil survey instrument. The target population for the national
survey is all facilities in the U.S. that use lower gastrointestinal
flexible endoscopic equipment for the detection of colorectal cancer in
adults. Information will be collected from a random sample of 1,440
facilities, stratified by U.S. Census region and urban/rural location.
Additional state-level surveys will be conducted from approximately
2010-2012 and will include a census survey of up to 18 selected states,
based on methodology employed with the previously fielded state-based
survey. An average of 135 facilities will be selected to participate in
each state. A total of approximately 1,680 completed state surveys will
be collected over the three years of the project.
Facilities will be recruited and screened through a telephone
interview. Participation is voluntary. The information collection will
inform planning efforts for national and state colorectal cancer
screening.
There are no costs to respondents other than their time. The total
estimated burden hours are 732.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Medical Facilities that Perform CRC National Survey 700 1 5/60
Screening. Recruitment Interview.
National SECAP Survey.. 480 1 35/60
State Survey 800 1 5/60
Recruitment Interview.
State SECAP Survey..... 560 1 35/60
----------------------------------------------------------------------------------------------------------------
Carol Walker,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2010-11413 Filed 5-12-10; 8:45 am]
BILLING CODE 4163-18-P
